BioAtla, Inc. SEC filings BCAB
BioAtla, Inc. has 509 filings in SEC EDGAR's recent list, going back to Oct 6, 2020. Its latest annual report, Form ARS, was filed on Jun 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (material agreement, agreement ended, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 29, 2026 | — |
| RW | Filing | Oct 27, 2026 | — |
| EFFECT | Filing | May 14, 2025 | — |
| CORRESP | Letter to the SEC | May 12, 2025 | — |
| UPLOAD | Letter from the SEC | May 9, 2025 | — |
| EFFECT | Filing | Jan 17, 2023 | — |
| CORRESP | Letter to the SEC | Jan 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2023 | — |
| EFFECT | Filing | May 18, 2022 | — |
| POSASR | Filing | Feb 28, 2022 | — |
| EFFECT | Filing | Nov 3, 2021 | — |
| CORRESP | Letter to the SEC | Nov 1, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 29, 2021 | — |
| EFFECT | Filing | Dec 15, 2020 | — |
| CERT | Filing | Dec 14, 2020 | — |
| CORRESP | Letter to the SEC | Dec 11, 2020 | — |
| CORRESP | Letter to the SEC | Dec 11, 2020 | — |
| SEC STAFF LETTER | Filing | Dec 10, 2020 | — |
| 8-A12B | Filing | Dec 9, 2020 | — |
| CORRESP | Letter to the SEC | Dec 9, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 8, 2020 | — |
| CORRESP | Letter to the SEC | Dec 8, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 4, 2020 | — |
| SEC STAFF LETTER | Filing | Nov 23, 2020 | — |
| CORRESP | Letter to the SEC | Nov 13, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2020 | — |
| DRS | Filing | Oct 6, 2020 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCAB (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1826892
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.